TL1A和IDO在口腔扁平苔藓患者外周血中的表达研究

›› 2015, Vol. 35 ›› Issue (4): 278-281.

TL1A和IDO在口腔扁平苔藓患者外周血中的表达研究

韩佳桐¹,翟爱荣¹,漆明²

1. 宁夏医科大学研究生院
2. 宁夏医科大学总医院口腔医院

收稿日期:2014-06-11 修回日期:2014-07-09 出版日期:2015-04-28 发布日期:2015-04-27
通讯作者: 漆明 E-mail:qiming61@sina.com

Expression of TL1A and IDO in the peripheral blood in the patients with oral lichen planus

Received:2014-06-11 Revised:2014-07-09 Online:2015-04-28 Published:2015-04-27

摘要/Abstract

摘要： 目的研究肿瘤坏死因子样配体1A（tumor necrosis factor-like ligand 1A，TL1A）和吲哚胺2，3双加氧酶（indoleamine 2，3-dioxygenase，IDO）在口腔扁平苔藓（OLP）患者外周血中的表达及其是否存在相关性。方法采用实时荧光定量聚合酶链反应（FQ-PCR）法检测30例OLP患者和30例健康人外周血单个核细胞中TL1A、IDO的基因表达水平。结果在OLP患者中，TL1A、IDO的基因表达水平均高于对照组（P＜0.05），结果经2-ΔΔCT转换后，OLP组TL1A、IDO mRNA表达水平分别是健康对照组的1.7872、2.0763倍。TL1A、IDO mRNA的表达水平无明显相关性（P>0.05）。结论 TL1A、IDO mRNA在OLP的发病中起了一定作用，两者的作用机制有待于进一步研究。

关键词: TL1A, IDO, 口腔扁平苔藓, 实时荧光定量PCR

Abstract: Objectives To investigate the expression of TL1A and IDO in normal oral mucosa (NOM) and oral lichen planus(OLP),and to observe their correlation of TL1A and IDO in OLP.Methods The expression levels of TL1A mRNA and IDO mRNA in the peripheral blood of 30 OLP patients and 30 cases of healthy human were detected using realtime fluorescent quantitativepolymerase chain reaction（FQPCR) technology.Results In the OLP group,the expression levels of TL1A,IDO mRNA were higher than those in the control group（P＜0.05）.After the conversion of the 2-ΔΔCT,the expression levels of TL1A,IDO mRNA in the OLP group were 1.7872 and 2.0763 times of the control group respectively.In the OLP group,the expression levels of TL1A mRNA and IDO mRNA had no obvious correlation（P>0.05）.Conclusions The abnormal expression of TL1A and IDO mRNA may play certain roles in the pathogenesis of OLP.The mechanism of action needs to be further studied.

Key words: TL1A, IDO, oral lichen planus, realtime fluorescent quantitative PCR

中图分类号:

R781.59

韩佳桐翟爱荣漆明. TL1A和IDO在口腔扁平苔藓患者外周血中的表达研究[J]. 口腔医学, 2015, 35(4): 278-281.

参考文献

[1]ZK（#〗Hus H,Viney JL.The tale of TL1A inflammation[J].MucosalImmunol,2011,4(4):368-370
[2]Meylan F,Richard AC,Siegel RM.TL1A and DR3,a TNF family ligandreceptor pair that promotes lymphocyte costimulation mucosal hyperplasia and autoimmune inflammation[J].Immunol Rev,2011,244(1):188-196
[3]BayryJ.Immunology:TL1A in inflammatory network in autoimmune diseases[J].Nat Rev Rheumatol,2010,6(2):67-68
[4]Bamias G,Martin C,Marini M,et al.Expression,localization,and functional activity of TL1A,a novel Th1polarizing cytokine in inflammatory bowel disease[J].J Immunol,2003,171(9):4868-4874
[5]Sucher R,Fischler K,Oberhuber R,et al.IDO and regulatory T cell support are critical for cytotoxic T lymphocyteassociated Ag4Igmediated longterm solid organ allograft survival[J].J Immunol,2012,188(1):37-46
[6]Gotoh A，Hamada Y，Shiobara N，et al.Skew in T cell receptor usage with poluclonal expansion in lesions of oral lichen planus without hepatitis Cvirus infection[J].Clin Exp Immunol,2008,154(2):192-201
[7]陈作良，曾夏梅，韩阳平,等.细胞在口腔扁平苔藓发病中的研究[J].口腔医学,2012,32(4):223-225
[8]Porter SR,Kirby A,Olaen I,et al.Immunologic aspects of dermal and oral lichenplanus:a review[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1997,83(3):358-366
[9]Khan A,Farah CS,Savage NW,et al.Th1cytokines in oral lichen planus[J].J Oral Pathol Med,2003,32(2):77-83
[10]曾娟，刘青兰，范媛.口腔扁平苔藓患者Th1/Th2的表达及临床意义的研究[J].口腔医学,2011,31(5):291-293
[11]Zhou G,Xia K,du GF,et al.Activation of nuclear factorkappa B correlates with tumor necrosis factoralpha in oral lichen planus :a clinicopathologic study in atrophicerosive and reticular form[J].J Oral Pathol Med,2009,38(7):559-564
[12]张婷，夏敏.TNFSF15基因与克罗恩病研究进展[J].国际消化病杂志,2010,30(4):206-209
[13]王慧，潘科，夏建川.IDO和CD4+CD25+调节性T细胞在肿瘤免疫逃逸中相互作用的研究进展[J].癌症,2009,28(2):221-224
[14]张防正，胡丽华.吲哚胺2，3双加氧酶的免疫调节功能研究新进展[J].中国免疫学杂志,2011,27(1):93-95
[15]Migone T S，Zhang J，Luo X，et al.TL1A is a TNFlike ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator[J].Immunity,2002,16(3):479-492
[16]Cho YG,Cho ML,Min SY.Type Ⅱcollagen autoimmunity in a mouse model of human rheumatoid arthritis[J].Autoimmun Rev,2007,7(1):65-70